This is the first study to investigate LAT1 expression in the homogeneous group of WHO grade II and III IDH-mutant astrocytomas, reporting an association of higher LAT1 expression with faster progression. The gene discussed is SLC7A5; the disease is astrocytoma (excluding glioblastoma).